Ag. Zeimet et al., CIRCULATING IMMUNOSTIMULATORY PROTEIN 90K AND SOLUBLE INTERLEUKIN-2-RECEPTOR IN HUMAN OVARIAN-CANCER, International journal of cancer, 68(1), 1996, pp. 34-38
The tumor-associated antigen 90K is thought to play an important role
in cellular immune defense against malignant cells. It is therefore of
interest to investigate whether circulating 90K could be used as a pr
ognostic variable in ovarian cancer, and whether this immunostimulator
y antigen is related to other parameters known to be involved in the c
ellular immune response. In the present retrospective study, circulati
ng levels of antigen 90K were measured before primary surgery in 152 o
varian-cancer patients. A very dose association between antigen 90K an
d s-IL-2R concentrations was pointed out in a stepwise logistic regres
sion model. Univariate analysis of overall survival revealed that anti
gen 90K and s-IL-2R were associated with poor prognosis. In the multiv
ariate Cox regression, however, neither antigen 90K nor s-IL-2R retain
ed independent prognostic significance. Urinary neopterin was shown to
be the only independent prognostic variable among the ''immunological
parameters'' investigated. Additionally, residual disease after prima
ry tumor debulking and histopathologic tumor grade were the most promi
nent clinico-pathologic parameters for the independent prediction of p
oor clinical outcome in ovarian-cancer patients. (C) 1996 Wiley-Liss,
Inc.